The FAST IMPACT Award funds major translational research to advance new therapies for Angelman syndrome from pre-clinical studies to IND-enabling stages, supporting innovative scientific approaches.
The FAST Impact Award funds innovative translational research to advance therapies for Angelman syndrome from pre-clinical stages to IND application readiness.
The FAST Innovation Seed Grant funds early-stage, high-risk research to advance new therapies, targets, and biomarkers for Angelman syndrome.
FAST’s New Investigator award funds early-career researchers advancing translational science and therapeutic innovation for Angelman syndrome.
The Innovation Seed Grant from FAST funds bold, early-stage research to advance scientific understanding and treatment options for Angelman syndrome.